![Brent Sabatini](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brent Sabatini
Financieel Directeur/CFO bij
VIR BIOTECHNOLOGY, INC.
Vermogen: 677 208 $ op 31-08-2026
Profiel
Brent Sabatini is Senior VP, Chief Financial & Accounting Officer at Vir Biotechnology, Inc. since 2026.
Formerly, Mr. Sabatini was Head-Finance at Capsida Biotherapeutics, Inc. from 2021 to 2023.
Education includes an MBA from Stephen M.
Ross School of Business and an undergraduate degree from The California State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-06-2026 | 61.902 ( 0,04% ) | 677 208 $ | 31-08-2026 |
Actieve functies van Brent Sabatini
| Bedrijven | Functie | Begin |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Financieel Directeur/CFO | 03-08-2026 |
Eerdere bekende functies van Brent Sabatini
| Bedrijven | Functie | Einde |
|---|---|---|
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Corporate Officer/Principal | 01-02-2023 |
Opleiding van Brent Sabatini
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
45
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
The California State University
 The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stephen M. Ross School of Business
 Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
